Cargando…

Cyclosporine has a potential role in the treatment of SARS

Detalles Bibliográficos
Autores principales:	Russell, Clark D., Haas, Juergen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133676/ https://www.ncbi.nlm.nih.gov/pubmed/23396219 http://dx.doi.org/10.1016/j.jinf.2013.01.004

Ejemplares similares

Cosmetically Disfiguring Side Effects of Cyclosporine
por: Panicker, Vinitha Varghese, et al.
Publicado: (2012)

Cyclosporine Effects on Pediatric Kidney Recipients
por: Hami, Maryam
Publicado: (2012)

Gingival enlargement due to Cyclosporine A therapy in aplastic anaemia
por: Sabnis, Girish R., et al.
Publicado: (2011)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

Effect of Erdosteine on Cyclosporine Induced Chronic Nephrotoxicity
por: Briguori, Carlo, et al.
Publicado: (2012)

Lichen striatus successfully treated with oral cyclosporine
por: Romita, Paolo, et al.
Publicado: (2017)

Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs
por: Skyschally, Andreas, et al.
Publicado: (2010)

Monitoring of Cyclosporine A Blood Levels in Clinical Settings
por: Niemczyk, Mariusz
Publicado: (2012)

Insights into the Possible Mechanism of Cyclosporine-Induced Chronic Nephrotoxicity; Arteriolopathy
por: Yoon, Sang Pil
Publicado: (2012)

Still the Joker in the Pack: When to Take Out Cyclosporine in the Game?
por: Resál, Tamás, et al.
Publicado: (2021)

Is the interaction between ticlopidine and cyclosporin dose related? Report of three cases
por: Houssaïni, Tarik Sqalli, et al.
Publicado: (2010)

A Pediatric Patient with Intravenous Cyclosporine Anaphylaxis Who Tolerated the Oral Form
por: Işık, Pamir, et al.
Publicado: (2014)

Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Pemphigus Vulgaris
por: Park, So Eun, et al.
Publicado: (2015)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

A Case of Kaposi's Varicelliform Eruption in a Patient with Psoriasis Receiving Cyclosporine Therapy
por: Külcü Çakmak, Seray, et al.
Publicado: (2015)

Cyclosporine Drug Levels: Comparison of the Architect 1000i with the Siemens Dimension RXL System
por: Chavan, Preeti, et al.
Publicado: (2015)

Has SARS-CoV-2 evolved and adapted to circulate at high temperatures?
por: Lippi, G., et al.
Publicado: (2022)

From Molière to SARS-CoV-2: How Medicine has changed
por: Perciaccante, A., et al.
Publicado: (2022)

A Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with Isotretinoin
por: Jung, Hwa Young, et al.
Publicado: (2016)

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation
por: Straathof, K, et al.
Publicado: (2017)

Toxic epidermal necrolysis in an 8-year-old girl successfully treated with cyclosporin A, intravenous immunoglobulin and plasma exchange
por: Zielińska, Marzena, et al.
Publicado: (2018)

Has the Required Importance Been given to the Diagnosis and Treatment of Prediabetes?
por: Yuce, Suleyman, et al.
Publicado: (2014)

No Association Between Cyclosporine Levels and Dyslipidemia?
por: Filler, Guido
Publicado: (2014)

Viral Antigen Detection in Blood (Serum) Has no Role in Laboratory Diagnosis of Rabies
por: Mani, Reeta S., et al.
Publicado: (2021)

Cyclosporine A and COVID-19 – The COQUIMA cohort
por: Schuurmans, Macé M., et al.
Publicado: (2020)

Cyclosporine A and COVID19 – The COQUIMA cohort
por: Sánchez-Pernaute, Olga
Publicado: (2020)

A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2
por: Luan, Junwen, et al.
Publicado: (2020)

The index case of SARS-CoV-2 in Scotland
por: Hill, Katherine J., et al.
Publicado: (2020)

Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
por: Nobile, B., et al.
Publicado: (2020)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Pentraxin 3: Potential prognostic role in SARS-CoV-2 patients admitted to the emergency department
por: Schirinzi, Annalisa, et al.
Publicado: (2021)

The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells
por: Tomita, Yuriko, et al.
Publicado: (2021)

The Role of a Geriatrician has Become Even More Important in an Academic Institution during COVID-19
por: Merchant, Reshma A., et al.
Publicado: (2020)

Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A
por: Niemczyk, Mariusz
Publicado: (2013)

Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
por: Salciccia, Stefano, et al.
Publicado: (2020)

Assigning developmental venous anomaly thrombosis to SARS-CoV-2 only when the causal connection has been proven
por: Finsterer, Josef
Publicado: (2023)

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
por: Reznik, Sandra E., et al.
Publicado: (2022)

ChatGPT has the potential to enhance antiretroviral therapy adherence among adolescents with HIV in sub-Saharan Africa
por: Kizito, Samuel
Publicado: (2023)

Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2
por: Skayem, Charbel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u1tet2u5jmkcubpe1jr7o9l439